IDBS secures Very High ELN Enterprise Vendor rating from Gartner for Biology and TransMed; Only Enterprise ELN Vendor to have a Very High rating in more than one category
(M2 PressWIRE Via Acquire Media NewsEdge) London, UK, and Boston, US -- IDBS, a global provider of innovative data management, analytics and modeling solutions, is one of only five firms out of 34 to be rated as an ELN Enterprise Vendor in Gartner's research report titled, 'Manufacturers Must Consider Scientific Domain Expertise During ELN Selection', published January 11, 2013. The report, based upon hundreds of customer and vendor conversations, also gave a Very High/High rating to IDBS' deep domain expertise across five of the six key scientific areas, namely Biology, Translational Medicine, Chemistry, Formulations and Regulated (process) Environments. It received a Medium rating for Engineering.
A 'Very High' rating means the vendor has excellent scientific domain capabilities and is approaching the 'de facto' standard. IDBS is the only Enterprise ELN Vendor to have a Very High rating in more than one category. The research is designed to be a starting source to create shortlists of vendors that best serve scientific and functional domains.
Neil Kipling, CEO and Founder of IDBS said, "We have a 20 year history of helping customers treat their R&D data as a capital asset. As the largest independent company in our sector we have moved fast and invested early to meet the needs of a newly data-centric R&D environment. For us, this report confirms that we provide an unparalleled breadth of capability in E-WorkBook. Our expanding customer base now ranges across multiple industries and scientific domains, from basic research through process development into translational research. All of them are benefitting from improved business insights and measurable efficiencies."
For more information or a full copy of the report, please visit: www.gartner.com (requires Gartner client access login)
IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company's uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.
IDBS' solutions help scientists, hospitals and R&D businesses produce the world's newest therapeutics, diagnostics and personalized treatments, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and consumer products.
Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan 'Enabling Technology' Award in R&D data management for 2010 and Queen's Award for International Trade 2011. Further information can be found at www.idbs.com, or follow us on Twitter @IDBSsoftware.
For further press details please contact Metia on behalf of IDBS:
+44 (0) 20 3100 3796
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com)).
(c) 2013 M2 COMMUNICATIONS
[ Back To TMCnet.com's Homepage ]